Ceratoses actínicas tratadas com ácido glicólico a 8%

Abstract

Actinic keratoses (AK) are common skin lesions, primarily induced by ultraviolet light, occurring mainly on the photoexposed skin surface. They represent the initial manifestation of proliferation of atypical intraepithelial keratinocytes with a potential of 0.25% - 20% per year progress to squamous cell carcinoma (SCC), which is metastasizing. They are clinically diagnosed and treated on an outpatient basis. They are prevalent worldwide, with higher distribution in light-skinned individuals of Fitzpatrick phototype I and II. There are several treatments (topical, surgical and systemic), prevention being the most important modality. Glycolic acid, the first of a series of alpha hydroxyacids, when applied topically in low concentrations (2% to 12%) in cream, gels or nonionic lotions, acts as an epidermolytic and keratolytic. This makes it an excellent asset in the treatment that we propose. Our objective was to investigate the effectiveness or otherwise of a new therapeutic approach to AK, assess patient adherence to treatment and observe the appearance of adverse reactions. The study was clinical, prospective, transversal in patients seen at the Geriatric Dermatology Clinic of HU / CAS UFJF, 50 individuals altogether. All patients had actinic keratoses on their face. The result show that total resolution of AK was not observed in all patients, but there was complete adherence to medication, adverse effects not being observed in the study population. We conclude that, although not completely effective for the disappearance of the lesions, it led to a marked decrease in the number of lesions and the severity index of these.